NO318469B1 - Anordning for implantering av biologisk materiale. - Google Patents
Anordning for implantering av biologisk materiale. Download PDFInfo
- Publication number
- NO318469B1 NO318469B1 NO20012942A NO20012942A NO318469B1 NO 318469 B1 NO318469 B1 NO 318469B1 NO 20012942 A NO20012942 A NO 20012942A NO 20012942 A NO20012942 A NO 20012942A NO 318469 B1 NO318469 B1 NO 318469B1
- Authority
- NO
- Norway
- Prior art keywords
- plunger
- sealing
- cells
- implantation
- biological material
- Prior art date
Links
- 238000002513 implantation Methods 0.000 title claims abstract description 16
- 239000012620 biological material Substances 0.000 title claims description 13
- 238000007789 sealing Methods 0.000 claims description 44
- 230000007246 mechanism Effects 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000003181 biological factor Substances 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 15
- 239000007943 implant Substances 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 8
- 238000011282 treatment Methods 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 210000003708 urethra Anatomy 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 32
- 206010029113 Neovascularisation Diseases 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000005304 joining Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 229940125721 immunosuppressive agent Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- -1 polytetrafluoroethylene Polymers 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- LEKIODFWYFCUER-UHFFFAOYSA-N 2-methylidenebut-3-enenitrile Chemical compound C=CC(=C)C#N LEKIODFWYFCUER-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011670 long-evans rat Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
- HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
- 229960000951 mycophenolic acid Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000021232 nutrient availability Nutrition 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA/A/1998/010667A MXPA98010667A (es) | 1998-12-15 | Procedimiento y dispositivo para favorecer el implante de material biologico | |
| PCT/MX1999/000039 WO2000035371A2 (es) | 1998-12-15 | 1999-12-14 | Procedimiento y dispositivo para favorecer el implante de material biologico |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20012942D0 NO20012942D0 (no) | 2001-06-14 |
| NO20012942L NO20012942L (no) | 2001-08-07 |
| NO318469B1 true NO318469B1 (no) | 2005-03-21 |
Family
ID=19745068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012942A NO318469B1 (no) | 1998-12-15 | 2001-06-14 | Anordning for implantering av biologisk materiale. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6716246B1 (zh) |
| EP (1) | EP1435220B1 (zh) |
| JP (1) | JP3722698B2 (zh) |
| KR (1) | KR100502285B1 (zh) |
| CN (1) | CN1204854C (zh) |
| AT (1) | ATE336207T1 (zh) |
| AU (1) | AU772166B2 (zh) |
| BR (1) | BR9917048A (zh) |
| CA (1) | CA2355675C (zh) |
| CY (1) | CY1106264T1 (zh) |
| CZ (1) | CZ302458B6 (zh) |
| DE (1) | DE69932866T2 (zh) |
| DK (1) | DK1435220T3 (zh) |
| EA (1) | EA003119B1 (zh) |
| EE (1) | EE04802B1 (zh) |
| ES (1) | ES2270626T3 (zh) |
| HK (1) | HK1067295A1 (zh) |
| HU (1) | HU226054B1 (zh) |
| IL (2) | IL143775A0 (zh) |
| IS (1) | IS2351B (zh) |
| LT (1) | LT5015B (zh) |
| LV (1) | LV12728B (zh) |
| NO (1) | NO318469B1 (zh) |
| NZ (1) | NZ512358A (zh) |
| PL (1) | PL191994B1 (zh) |
| PT (1) | PT1435220E (zh) |
| RO (1) | RO120313B1 (zh) |
| SI (1) | SI20847B (zh) |
| SK (1) | SK285392B6 (zh) |
| TR (1) | TR200101769T2 (zh) |
| WO (1) | WO2000035371A2 (zh) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
| EP1253854A4 (en) | 1999-03-07 | 2010-01-06 | Discure Ltd | METHOD AND APPARATUS FOR COMPUTERIZED SURGERY |
| US20050265977A1 (en) * | 1999-04-30 | 2005-12-01 | Elliott Robert B | Xenotransplant for CNS therapy |
| US20090047325A1 (en) * | 1999-04-30 | 2009-02-19 | Neurotrophincell Pty. Limited | Xenotransplant for cns therapy |
| WO2000066188A2 (en) * | 1999-04-30 | 2000-11-09 | Diatranz Limited | Xenotransplant for cns therapy |
| WO2001052871A1 (en) * | 2000-01-20 | 2001-07-26 | Diatranz Limited | Preparation and xenotransplantation of porcine islets |
| AU1112202A (en) * | 2000-10-17 | 2002-04-29 | Diatranz Ltd | Preparation and xenotransplantation or porcine islets |
| EP1373609A1 (en) * | 2001-03-26 | 2004-01-02 | University College London | Method for forming hardened tubes and sheets |
| US20050042746A1 (en) * | 2001-09-28 | 2005-02-24 | Olga Garkavenko | Growing xenotransplant material in culture |
| NZ515310A (en) * | 2001-11-07 | 2004-08-27 | Diabcell Pty Ltd | Methods of treatment and delivery modes |
| EP1636346A4 (en) * | 2003-06-24 | 2007-03-28 | Diabcell Pty Ltd | FROM PIG CULTIVATED PIG ISLE CELLS FOR XENOTRANSPLANTATION |
| US20050118145A1 (en) * | 2003-07-03 | 2005-06-02 | Jannette Dufour | Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| US8916184B2 (en) * | 2003-11-07 | 2014-12-23 | University Of Connecticut | Artificial tissue systems and uses thereof |
| RU2401084C2 (ru) * | 2004-07-29 | 2010-10-10 | Юниверсити Оф Майами | Гибридное устройство для клеточной терапии |
| WO2006130851A2 (en) * | 2005-06-02 | 2006-12-07 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized devices and related methods |
| NZ540597A (en) * | 2005-06-08 | 2007-02-23 | Neurotrophincell Pty Ltd | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells |
| CA2658951A1 (en) * | 2006-07-28 | 2008-01-31 | Sertocell Biotechnology (Us) Corp. | Adult sertoli cells and uses thereof |
| US8506636B2 (en) | 2006-09-08 | 2013-08-13 | Theken Spine, Llc | Offset radius lordosis |
| AU2008214423A1 (en) | 2007-02-02 | 2008-08-14 | Converge Biotech Inc. | Therapeutic hybrid implantable devices |
| EA018285B1 (ru) * | 2007-08-31 | 2013-06-28 | Китозим Са | Протез для стимулирования восстановления in vivo полого органа или части полого органа |
| ES2932850T3 (es) * | 2008-11-14 | 2023-01-27 | Viacyte Inc | Encapsulación de células pancreáticas derivadas de células madre pluripotentes humanas |
| SG10201405256VA (en) * | 2009-08-28 | 2014-10-30 | Sernova Corp | Device for cellular transplantation and uses thereof |
| AU2016203097A1 (en) * | 2009-08-28 | 2016-06-02 | Sernova Corporation | Methods And Devices For Cellular Transplantation |
| AU2014200845B2 (en) * | 2009-08-28 | 2016-05-12 | Sernova Corporation | Methods and Devices for Cellular Transplantation |
| MX2010013135A (es) * | 2010-11-30 | 2012-05-31 | Val De Bio S De R L De C V | Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico. |
| ES2637640T3 (es) | 2011-04-29 | 2017-10-16 | Converge Biotech Inc. | Recubrimiento conformal de células para inmunoaislamiento |
| CN103110436B (zh) * | 2013-03-11 | 2015-05-13 | 刘亚平 | 一种椎体内神经占位器 |
| US10130288B2 (en) | 2013-03-14 | 2018-11-20 | Cell and Molecular Tissue Engineering, LLC | Coated sensors, and corresponding systems and methods |
| US10405961B2 (en) | 2013-03-14 | 2019-09-10 | Cell and Molecular Tissue Engineering, LLC | Coated surgical mesh, and corresponding systems and methods |
| CN110960733B (zh) * | 2019-12-19 | 2022-03-15 | 广州市妇女儿童医疗中心 | 一种用于植入受试者皮下组织的新血管构建体及其制备方法 |
| WO2021222469A1 (en) | 2020-04-28 | 2021-11-04 | University Of Miami | Conformal coating of cells for immunoisolation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| US5100392A (en) * | 1989-12-08 | 1992-03-31 | Biosynthesis, Inc. | Implantable device for administration of drugs or other liquid solutions |
| EP0587840B1 (en) * | 1992-02-24 | 1999-12-15 | Encelle, Inc. | Bioartificial endocrine device |
| WO1995008355A1 (en) | 1993-09-24 | 1995-03-30 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
| US5492826A (en) * | 1993-12-10 | 1996-02-20 | William Beaumont Hospital | Apparatus and method for seeding endothelial cells |
| ATE212230T1 (de) * | 1994-04-13 | 2002-02-15 | Res Corp Technologies Inc | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat |
| US5741334A (en) * | 1995-06-07 | 1998-04-21 | Circe Biomedical, Inc. | Artificial pancreatic perfusion device |
| US6136296A (en) * | 1997-04-25 | 2000-10-24 | The Procter & Gamble Company | Personal care compositions |
| US6117166A (en) * | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
-
1999
- 1999-12-14 ES ES99961495T patent/ES2270626T3/es not_active Expired - Lifetime
- 1999-12-14 EP EP99961495A patent/EP1435220B1/en not_active Expired - Lifetime
- 1999-12-14 WO PCT/MX1999/000039 patent/WO2000035371A2/es active IP Right Grant
- 1999-12-14 PL PL352559A patent/PL191994B1/pl unknown
- 1999-12-14 AU AU18057/00A patent/AU772166B2/en not_active Ceased
- 1999-12-14 SK SK829-2001A patent/SK285392B6/sk unknown
- 1999-12-14 JP JP2000587693A patent/JP3722698B2/ja not_active Expired - Fee Related
- 1999-12-14 NZ NZ512358A patent/NZ512358A/xx not_active IP Right Cessation
- 1999-12-14 CN CNB998145017A patent/CN1204854C/zh not_active Expired - Fee Related
- 1999-12-14 KR KR10-2001-7007368A patent/KR100502285B1/ko not_active IP Right Cessation
- 1999-12-14 AT AT99961495T patent/ATE336207T1/de active
- 1999-12-14 HU HU0203247A patent/HU226054B1/hu not_active IP Right Cessation
- 1999-12-14 TR TR2001/01769T patent/TR200101769T2/xx unknown
- 1999-12-14 IL IL14377599A patent/IL143775A0/xx active IP Right Grant
- 1999-12-14 CZ CZ20012158A patent/CZ302458B6/cs not_active IP Right Cessation
- 1999-12-14 DE DE69932866T patent/DE69932866T2/de not_active Expired - Lifetime
- 1999-12-14 CA CA002355675A patent/CA2355675C/en not_active Expired - Fee Related
- 1999-12-14 RO ROA200100681A patent/RO120313B1/ro unknown
- 1999-12-14 DK DK99961495T patent/DK1435220T3/da active
- 1999-12-14 EE EEP200100325A patent/EE04802B1/xx not_active IP Right Cessation
- 1999-12-14 PT PT99961495T patent/PT1435220E/pt unknown
- 1999-12-14 EA EA200100664A patent/EA003119B1/ru not_active IP Right Cessation
- 1999-12-14 BR BR9917048-5A patent/BR9917048A/pt not_active IP Right Cessation
- 1999-12-14 US US09/868,103 patent/US6716246B1/en not_active Expired - Lifetime
- 1999-12-14 SI SI9920095A patent/SI20847B/sl not_active IP Right Cessation
-
2001
- 2001-06-13 LT LT2001062A patent/LT5015B/lt not_active IP Right Cessation
- 2001-06-14 IS IS5968A patent/IS2351B/is unknown
- 2001-06-14 IL IL143775A patent/IL143775A/en not_active IP Right Cessation
- 2001-06-14 NO NO20012942A patent/NO318469B1/no not_active IP Right Cessation
- 2001-06-15 LV LVP-01-93A patent/LV12728B/en unknown
-
2004
- 2004-12-29 HK HK04110296A patent/HK1067295A1/xx not_active IP Right Cessation
-
2006
- 2006-11-13 CY CY20061101634T patent/CY1106264T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO318469B1 (no) | Anordning for implantering av biologisk materiale. | |
| US20050136092A1 (en) | Implantable device | |
| CA3043468C (en) | Percutaneous gas diffusion device suitable for use with a subcutaneous implant | |
| DK2621403T3 (en) | An implantable cell device with supporting and radial diffusible structure | |
| NO309124B1 (no) | Kunstige biologiske anordninger for frigivelse av hormoner | |
| Uchida et al. | Myogenic tone in isolated perfused resistance vessels from rats | |
| EP2647351A1 (en) | Flat device for facilitating the transplant of biological material | |
| MXPA98010667A (es) | Procedimiento y dispositivo para favorecer el implante de material biologico | |
| US20110172595A1 (en) | Implantable site with septum prestressed in two directions | |
| RU2265446C2 (ru) | Имплантат для лечения болезни паркинсона |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |